Publications by authors named "Mathilde Saint Ghislain"

Claim this Profile
E
Evaluation of risk-reducing radical fimbriectomy followed by delayed oophorectomy in high-risk Women: A single-center retrospective study.
Sophie Schoenen, Carlos Martinez Gomez, Camille Pasquesoone, Julie Alline, Mathilde Duchatelet, Mathilde Saint-Ghislain

Eur J Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.
Edith Borcoman, Bastien Cabarrou, Miguel Francisco, Frédéric Bigot, François Ghiringhelli, Mathilde Saint-Ghislain

Nat Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO).
Raphaël Leman, François Cherifi, Marianne Leheurteur, Pierrick Theret, Camille Pasquesoone, Mathilde Saint-Ghislain

BMC Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial MRI findings predictive of a pathological complete response to neoadjuvant treatments in HER2-positive breast cancers.
Anne Ribrag, Emilie Lissavalid, Juliette Fayard, Lounes Djerroudi, Mathilde Saint Ghislain

Eur J Radiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma.
Stéphane Champiat, Hélène Salaün, Francesca Lucibello, Jean-Yves Scoazec, Benjamin Besse, Mathilde Saint-Ghislain

JCO Precis Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction.
Maya Nourieh, Roseline Vibert, Mathilde Saint-Ghislain, Joanna Cyrta, Anne Vincent-Salomon

Histopathology· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients.
Mathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, Lauris Gastaud, Thierry Lesimple

Eur J Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients.
Hélène Salaün, Leanne de Koning, Mathilde Saint-Ghislain, Vincent Servois, Toulsie Ramtohul

Oncoimmunology· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Homologous recombination deficiency and PARP inhibitors in therapeutics].
Hélène Salaün, Mathilde Saint-Ghislain, Audrey Bellesoeur, Philippe Beuzeboc, Cindy Neuzillet

Bull Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabazitaxel activity in men with metastatic castration-resistant prostate cancer with and without DNA damage repair defects.
Mihaela Aldea, Laurent Lam, Emeline Orillard, Casilda Llacer Perez, Mathilde Saint-Ghislain

Eur J Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events of targeted therapies approved for women's cancers.
Mathilde Saint-Ghislain, Chloé Levenbruck, Audrey Bellesoeur

Int J Womens Dermatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of evidence for CDK12 as an ovarian cancer predisposing gene.
Alexandre Eeckhoutte, Mathilde Saint-Ghislain, Manon Reverdy, Virginie Raynal, Sylvain Baulande

Fam Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial.
Clémence Basse, Claire Morel, Céline Callens, Gaëlle Pierron, Vincent Servois, Mathilde Saint-Ghislain

JCO Precis Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative complications after bowel endometriosis surgery by shaving, disc excision, or segmental resection: a three-arm comparative analysis of 364 consecutive cases.
Carole Abo, Salwa Moatassim, Noemie Marty, Mathilde Saint Ghislain, Emmanuel Huet

Fertil Steril· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer.
Anne Perdrix, Mathilde Saint-Ghislain, Marie Degremont, Marion David, Zena Khaznadar

Reprod Biomed Online· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[What biomarkers for the future? The point of view of the residents in oncology after the ESMO 2016 Congress].
Marie Auvray, Marc-Antoine Benderra, Marie Bretagne, Sara Faouzi, Loïc Lebellec, Mathilde Saint-Ghislain

Bull Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis